01 September 1997
Antimicrobial susceptibility of common bacterial pathogens isolated from lower respiratory tract infections in Poland in 1996 - the Alexander Project
Krzysztof Trzciński, Waleria Hryniewicz, The Alexander Project Collaborative GroupMed Sci Monit 1997; 3(5): EP714-722 :: ID: 501672
Abstract
In 1996, the Alexander Project, an international multi-centre study on the antimicrobial susceptibility of bacterial pathogens isolated from community-acquired lower respiratory tract infections (LRTI) commenced in Poland. Altogether 506 bacterial isolates were collected from sputum, broncho-alveolar and blood samples taken from patients diagnosed with LRTI. Of these, 262 were identified as Haemophilus influenzae (51.8% of all isolates), 154 as Streptococcus pneumoniae (30.4%), 60 as Moraxella catarrhalis (11.9%) and 30 as Staphylococcus aureus (5.9%). All strains were analysed according to their susceptibility to a wide set of antimicrobial agents by the broth microdilution method. Ten H. influenzae strains (3.8%) were identified as ampicillin-resistant, beta-lactamase-positive. In 6 other isolates (2.3%) lowered susceptibility to ampicillin without beta-lactamase production was detected, which may be indicate that these are ampicillin-resistant, beta-lactamase-negative (BLNAR) H. influenzae. Twenty two Streptococcus pneumoniae isolates (14.3%) were identified as penicillin non-susceptible pneumococci (PNSP). In this group of pneumococcal isolates, multi-drug resistance was observed. Among PNSP, only 18.2% were susceptible to doxycycline, 27.3% to co-trimoxazole, 36.4% to erythromycin, and 68.8% to chloramphenicol. Twelve (7.8%) PNSP isolates have been identified as intermediately susceptible to penicillin (MIC ranging from 0.12 to 1 mg/l) and all were susceptible to amoxicillin. Over 80% of M. catarrhalis and S. aureus isolates were beta-lactamase positive. Of the antimicrobial agents analysed over 90% of isolates were identified as being susceptible to ceftriaxone, amoxicillin with clavulanic acid, cefuroxime, ciprofloxacin and ofloxacin.
The Alexander Project is organised and funded by SmithKline Beecham.
Keywords: Alexander Project, lower respiratory tract infections, antibiotic resistance
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952